Form 4: Elanco Animal Health Executive Rajeev A. Modi Reports Stock and Option Grants

Rajeev A. Modi, an executive at Elanco Animal Health, reported the acquisition of restricted stock units and stock options, as well as deferred stock units.

Summary

• On March 3, 2025, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported transactions involving Elanco's common stock and derivative securities.
• Modi acquired 28,736 shares of common stock through restricted stock units, 60,297 stock options, and 5,478 deferred stock units.
• The restricted stock units vest in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028.
• The stock options, with an exercise price of $11.31, also vest in three equal installments on the same dates as the restricted stock units.
• The deferred stock units vest on December 31, 2026, and will be settled upon termination of employment or as per the Executive Deferral and Stock Match Plan.
• Following these transactions, Modi directly owns 116,798 shares of Elanco common stock, 60,297 stock options, and 5,478 deferred stock units.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. The sentiment is neutral as it doesn't inherently suggest positive or negative implications for the company's performance.

Positives

• The grant of restricted stock units and stock options to an executive suggests the company's commitment to incentivizing and retaining key personnel.
• The vesting schedules of the grants (2026-2028) align the executive's interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the stock grants suggest a focus on long-term performance.

Industry Context

Stock grants and option awards are common practices in the animal health industry to attract, retain, and incentivize top talent. These grants align executive compensation with shareholder value and company performance.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation practices among publicly traded animal health companies such as Zoetis and IDEXX Laboratories.
• The vesting schedules (three years) are also typical for these types of equity awards, aligning with industry norms for long-term incentive plans.
• The size of the grant relative to Modi's position as Executive Vice President would need to be compared against peer companies to determine if it is above or below industry averages.

Stakeholder Impact

• Shareholders may view the stock grants as a positive sign, indicating that management's interests are aligned with theirs.
• Employees may see the grants as a sign of the company's commitment to rewarding and retaining talent.

Key Dates